Omnicell Inc
NASDAQ:OMCL
Omnicell Inc
Cash from Operating Activities
Omnicell Inc
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Omnicell Inc
NASDAQ:OMCL
|
Cash from Operating Activities
$181.1m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
12%
|
CAGR 10-Years
13%
|
|
Veeva Systems Inc
NYSE:VEEV
|
Cash from Operating Activities
$911.3m
|
CAGR 3-Years
18%
|
CAGR 5-Years
24%
|
CAGR 10-Years
36%
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Cash from Operating Activities
$24.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Evolent Health Inc
NYSE:EVH
|
Cash from Operating Activities
$142.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Doximity Inc
NYSE:DOCS
|
Cash from Operating Activities
$179.6m
|
CAGR 3-Years
90%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
Cash from Operating Activities
$138.3m
|
CAGR 3-Years
2%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
See Also
What is Omnicell Inc's Cash from Operating Activities?
Cash from Operating Activities
181.1m
USD
Based on the financial report for Dec 31, 2023, Omnicell Inc's Cash from Operating Activities amounts to 181.1m USD.
What is Omnicell Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
13%
Over the last year, the Cash from Operating Activities growth was 133%. The average annual Cash from Operating Activities growth rates for Omnicell Inc have been -1% over the past three years , 12% over the past five years , and 13% over the past ten years .